Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Acta Odontologica Latinoamericana : AOL|October 31, 2019
Student learning strategies according to years spent studying for a degree in dentistryÁngela B Argentieri, Cristina B Culacciati, Lucía T Basterrechea, et al.
Educacion Medica Y Salud|January 1, 1986
[Evaluation of non-conventional teaching methods]N E Bordoni, L Pereyra de Cantón, A Pérez de Galli, et al.
Diabetes, Nutrition & Metabolism|May 13, 2005
Microalbuminuria, brain vasomotor reactivity, carotid and kidney arterial flow in Type 2 diabetes mellitusF Gregorio, F Ambrosi, F Carle, et al.
The International Journal of Artificial Organs|December 1, 1986
Polycentric 384-month study of biofiltration (BF) with AN69sV Mioli, A Albertazzi, C Baroni, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2011
Hematologic outcomes of myelodysplastic syndromes treatment with hypomethylating agents in community practiceRodolfo E Bordoni, Bruce A Feinberg, James W Gilmore, et al.
The International Journal of Artificial Organs|December 1, 1986
Effects of chronic biofiltration with PAN membranes on acid-base status: polycentric studyR Tarchini, A Albertazzi, C Baroni, et al.
Nephron|January 1, 1992
HBV infection in hemodialysis patients: monitoring and preventionP Carletti, L Bibiano, R Boggi, et al.
Cancer Chemotherapy and Pharmacology|September 24, 2015
Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC)Daniel J Allendorf, Rodolfo E Bordoni, Stefan C Grant, et al.
Blood|October 18, 2017
Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged ≥60 years with HLJonathan W Friedberg, Andres Forero-Torres, Rodolfo E Bordoni, et al.
Blood|September 18, 2015
Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and olderAndres Forero-Torres, Beata Holkova, Jerome Goldschmidt, et al.
Pageof 3